Asian Phytoceuticals Financials
| APCO Stock | THB 4.94 0.08 1.65% |
Asian |
Understanding current and past Asian Phytoceuticals Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Asian Phytoceuticals' financial statements are interrelated, with each one affecting the others. For example, an increase in Asian Phytoceuticals' assets may result in an increase in income on the income statement.
The data published in Asian Phytoceuticals' official financial statements usually reflect Asian Phytoceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Asian Phytoceuticals. For example, before you start analyzing numbers published by Asian accountants, it's critical to develop an understanding of what Asian Phytoceuticals' liquidity, profitability, and earnings quality are in the context of the Personal Products space in which it operates.
Please note, the presentation of Asian Phytoceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Asian Phytoceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Asian Phytoceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Asian Phytoceuticals Public. Please utilize our Beneish M Score to check the likelihood of Asian Phytoceuticals' management manipulating its earnings.
Asian Phytoceuticals Stock Summary
Asian Phytoceuticals competes with Beauty Community, Jay Mart, MC Group, and Mega Lifesciences. Asian Phytoceuticals Public Company Limited engages in the research and development, manufacture, and distribution of health and natural beauty products in Thailand. Asian Phytoceuticals Public Company Limited was founded in 1988 and is headquartered in Lamphun, Thailand. ASIAN PHYTOCEUTICALS operates under Household Personal Products classification in Thailand and is traded on Stock Exchange of Thailand.| Foreign Associate | USA |
| Instrument | Thailand Stock View All |
| Exchange | Thailand Exchange |
| ISIN | TH1077A10Z09 |
| Business Address | 843 Moo 4 |
| Sector | Personal Products |
| Industry | Consumer Staples |
| Benchmark | NYSE Composite |
| Website | www.apco.co.th |
| Phone | 66 5 358 1374 |
| Currency | THB - Thailand Baht |
You should never invest in Asian Phytoceuticals without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Asian Stock, because this is throwing your money away. Analyzing the key information contained in Asian Phytoceuticals' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Asian Phytoceuticals Key Financial Ratios
Generally speaking, Asian Phytoceuticals' financial ratios allow both analysts and investors to convert raw data from Asian Phytoceuticals' financial statements into concise, actionable information that can be used to evaluate the performance of Asian Phytoceuticals over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Asian Phytoceuticals reports annually and quarterly.Asian Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Asian Phytoceuticals's current stock value. Our valuation model uses many indicators to compare Asian Phytoceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Asian Phytoceuticals competition to find correlations between indicators driving Asian Phytoceuticals's intrinsic value. More Info.Asian Phytoceuticals Public is number one stock in return on equity category among related companies. It is number one stock in return on asset category among related companies reporting about 0.61 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Asian Phytoceuticals Public is roughly 1.63 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Asian Phytoceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Asian Phytoceuticals' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Asian Phytoceuticals' earnings, one of the primary drivers of an investment's value.Asian Phytoceuticals Systematic Risk
Asian Phytoceuticals' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Asian Phytoceuticals volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Asian Phytoceuticals correlated with the market. If Beta is less than 0 Asian Phytoceuticals generally moves in the opposite direction as compared to the market. If Asian Phytoceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Asian Phytoceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Asian Phytoceuticals is generally in the same direction as the market. If Beta > 1 Asian Phytoceuticals moves generally in the same direction as, but more than the movement of the benchmark.
About Asian Phytoceuticals Financials
What exactly are Asian Phytoceuticals Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Asian Phytoceuticals' income statement, its balance sheet, and the statement of cash flows. Potential Asian Phytoceuticals investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Asian Phytoceuticals investors may use each financial statement separately, they are all related. The changes in Asian Phytoceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Asian Phytoceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze Asian Phytoceuticals Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Asian Phytoceuticals is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Asian has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Asian Phytoceuticals' financials are consistent with your investment objective using the following steps:- Review Asian Phytoceuticals' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Asian Phytoceuticals' liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Asian Phytoceuticals' financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Asian Phytoceuticals' stock is overvalued or undervalued.
Asian Phytoceuticals April 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Asian Phytoceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Asian Phytoceuticals Public. We use our internally-developed statistical techniques to arrive at the intrinsic value of Asian Phytoceuticals Public based on widely used predictive technical indicators. In general, we focus on analyzing Asian Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Asian Phytoceuticals's daily price indicators and compare them against related drivers.
| Information Ratio | (0.18) | |||
| Maximum Drawdown | 10.05 | |||
| Value At Risk | (2.68) | |||
| Potential Upside | 1.65 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Asian Phytoceuticals Public. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Asian Stock analysis
When running Asian Phytoceuticals' price analysis, check to measure Asian Phytoceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Asian Phytoceuticals is operating at the current time. Most of Asian Phytoceuticals' value examination focuses on studying past and present price action to predict the probability of Asian Phytoceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Asian Phytoceuticals' price. Additionally, you may evaluate how the addition of Asian Phytoceuticals to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |